In today’s globalised world, counterfeit pharmaceuticals have emerged as a silent epidemic, endangering the health and lives of millions. The…
Read More
#pharmaceuticals
Filter By
2023 Patent Landscape Report: COVID-19-related vaccines and therapeutics
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….
Read More
Unravelling the mysteries of motor neurone disease
Motor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read More
Are smartphones about to get smarter? With terahertz spectroscopy, it certainly looks that way…
The number of UK smartphones users reached 55.5 million in 2021. This means that nearly 83% of the population have…
Read More
Can you keep a trade secret? Understanding pharmaceutical IP
Patents are the ‘go-to’ form of Intellectual Property (IP) protection for new pharmaceuticals. Through patents, protection can be attained for…
Read More
The verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…
Read More
Plausibility at the EPO – how much data or experimental information is enough?
A patent for an invention provides its owner with the right to exclude others from making, using, offering for sale…
Read More